About Us
Enlyte News
There’s always something going on at Enlyte. Stay up to date with the latest developments.
Symbicort Generic Approval on March 15, 2022
Recently the U.S. Food and Drug Administration (FDA) approved a generic formulation of Symbicort metered-dose inhaler for the treatment of asthma or chronic obstructive pulmonary disease (COPD).
Mitchell Diagnostics Platform Surpasses 30,000 ADAS Calibrations
Demand continues to grow for company’s Diagnostics as a Service (DaaS) solutions designed to help collision repairers efficiently perform calibrations in-house SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the
Mazda Launches Collision Network to Consumers
New online resources including a facility locator make it easy for vehicle owners to find auto body shops that meet Mazda’s high standards for proper and safe repair
Enlyte 2022 Workers’ Comp Predictions Reveal Staffing Pinch
New York State Workers’ Compensation Board Announces Launch Dates for OnBoard Limited Release
The New York Workers’ Compensation Board is implementing an online system called OnBoard, which will replace the paper-based claims systems and eCase system with a single, web-based platform.
Jill Harris: For Workers’ Comp Industry, Navigating Provider Shortage Requires Fresh Thinking
Opioid Addiction Drug Buprenorphine Increases Risk of Dental Issues According to FDA
The FDA recently issued a warning concerning the risk of dental problems resulting from medications used to treat opioid addiction and pain.
See the P&C Industry From Our 360-Degree Vantage Point
In an ever-changing landscape, trusted knowledge is like gold. We’re the insiders you can count on to break down the opportunities and challenges facing the industry today, with the expertise to share actionable insights.
